Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer.

Although this study showed a trend of increased survival rate in the good pTRG group, it is likely that the patient's overall sample size and death events were not enough to derive significant results.

also in 53,322 other papers